PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22896926-0	2012	Gentamicin affects connexin 26 expression in the cochlear lateral wall.	Gentamicins	0-10	gap junction protein, beta 2	Rattus norvegicus	19-30	
22896926-3	2012	We examined the effects of gentamicin on the expression of connexin 26 to obtain a better understanding of aminoglycoside ototoxicity.	Gentamicins	27-37	gap junction protein, beta 2	Rattus norvegicus	59-70	
22896926-4	2012	METHODS: We detected changes in connexin 26 protein and mRNA expression in the cochlear lateral wall using immunohistochemistry staining, western blotting, and real-time PCR in rats after administration of a single dose of gentamicin.	Gentamicins	223-233	gap junction protein, beta 2	Rattus norvegicus	32-43	
22896926-5	2012	RESULTS: The expression of connexin 26 increased over time in type III fibrocytes after gentamicin administration.	Gentamicins	88-98	gap junction protein, beta 2	Rattus norvegicus	27-38	
22896926-6	2012	Elevated protein levels were detected 3 h after the single injection of gentamicin; while, mRNA levels increased after 24 h. CONCLUSION: Connexin 26 plays an important role in the acute effects of high-dose gentamicin and is probably involved in the pathogenesis of ototoxic deafness.	Gentamicins	72-82	gap junction protein, beta 2	Rattus norvegicus	137-148	
22896926-6	2012	Elevated protein levels were detected 3 h after the single injection of gentamicin; while, mRNA levels increased after 24 h. CONCLUSION: Connexin 26 plays an important role in the acute effects of high-dose gentamicin and is probably involved in the pathogenesis of ototoxic deafness.	Gentamicins	207-217	gap junction protein, beta 2	Rattus norvegicus	137-148